Assessing Immune Biomarkers in Tumor Microenvironments to Provide Predictive Responses
Time: 1:30 pm
day: Conference Day One
Details:
- Understanding the potential of these biomarkers by observing their behavior in the context of vaccine checkpoints and combinations to identify which biomarkers are most closely associated with positive outcomes
- Considering the characteristics of the tumor to understand what certain cancer subtypes may be more amenable to vaccine therapy than others
- Exploring the factors that influence these biomarkers and the immune response they elicit, to develop more effective vaccines
